These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


345 related items for PubMed ID: 35460412

  • 1. Insights into ovarian response with a fixed low dose FSH stimulation in an IUI programme: the PRORAILS study.
    Rutten A, van Ballegooijen H, Broekmans F, Cohlen B, PRORAILS study group.
    Hum Reprod; 2022 Jun 30; 37(7):1440-1450. PubMed ID: 35460412
    [Abstract] [Full Text] [Related]

  • 2. Individualized FSH dosing based on ovarian reserve testing in women starting IVF/ICSI: a multicentre trial and cost-effectiveness analysis.
    van Tilborg TC, Oudshoorn SC, Eijkemans MJC, Mochtar MH, van Golde RJT, Hoek A, Kuchenbecker WKH, Fleischer K, de Bruin JP, Groen H, van Wely M, Lambalk CB, Laven JSE, Mol BWJ, Broekmans FJM, Torrance HL, OPTIMIST study group.
    Hum Reprod; 2017 Dec 01; 32(12):2485-2495. PubMed ID: 29121350
    [Abstract] [Full Text] [Related]

  • 3. Birthweight and other perinatal outcomes of singletons conceived after assisted reproduction compared to natural conceived singletons in couples with unexplained subfertility: follow-up of two randomized clinical trials.
    Wessel JA, Mol F, Danhof NA, Bensdorp AJ, Tjon-Kon Fat RI, Broekmans FJM, Hoek A, Mol BWJ, Mochtar MH, van Wely M, INeS and SUPER Study Group.
    Hum Reprod; 2021 Feb 18; 36(3):817-825. PubMed ID: 33347597
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pretreatment with luteal estradiol for programming antagonist cycles compared to no pretreatment in advanced age women stimulated with corifollitropin alfa: a non-inferiority randomized controlled trial.
    Cédrin-Durnerin I, Carton I, Massin N, Chevalier N, Dubourdieu S, Bstandig B, Michelson X, Goro S, Jung C, Guivarc'h-Lévêque A.
    Hum Reprod; 2024 Sep 01; 39(9):1979-1986. PubMed ID: 39008826
    [Abstract] [Full Text] [Related]

  • 6. A randomized, controlled, first-in-patient trial of choriogonadotropin beta added to follitropin delta in women undergoing ovarian stimulation in a long GnRH agonist protocol.
    Fernández Sánchez M, Višnová H, Larsson P, Yding Andersen C, Filicori M, Blockeel C, Pinborg A, Khalaf Y, Mannaerts B, Rainbow Study Group.
    Hum Reprod; 2022 May 30; 37(6):1161-1174. PubMed ID: 35451013
    [Abstract] [Full Text] [Related]

  • 7. Follicle stimulating hormone versus clomiphene citrate in intrauterine insemination for unexplained subfertility: a randomized controlled trial.
    Danhof NA, van Wely M, Repping S, Koks C, Verhoeve HR, de Bruin JP, Verberg MFG, van Hooff MHA, Cohlen BJ, van Heteren CF, Fleischer K, Gianotten J, van Disseldorp J, Visser J, Broekmans FJM, Mol BWJ, van der Veen F, Mochtar MH, SUPER study group.
    Hum Reprod; 2018 Oct 01; 33(10):1866-1874. PubMed ID: 30137325
    [Abstract] [Full Text] [Related]

  • 8. The BISTIM study: a randomized controlled trial comparing dual ovarian stimulation (duostim) with two conventional ovarian stimulations in poor ovarian responders undergoing IVF.
    Massin N, Abdennebi I, Porcu-Buisson G, Chevalier N, Descat E, Piétin-Vialle C, Goro S, Brussieux M, Pinto M, Pasquier M, Bry-Gauillard H.
    Hum Reprod; 2023 May 02; 38(5):927-937. PubMed ID: 36864699
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Corifollitropin alfa followed by highly purified HMG versus recombinant FSH in young poor ovarian responders: a multicentre randomized controlled clinical trial.
    Drakopoulos P, Vuong TNL, Ho NAV, Vaiarelli A, Ho MT, Blockeel C, Camus M, Lam AT, van de Vijver A, Humaidan P, Tournaye H, Polyzos NP.
    Hum Reprod; 2017 Nov 01; 32(11):2225-2233. PubMed ID: 29040589
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of follitropin alfa/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders.
    Humaidan P, Chin W, Rogoff D, D'Hooghe T, Longobardi S, Hubbard J, Schertz J, ESPART Study Investigators‡.
    Hum Reprod; 2017 Mar 01; 32(3):544-555. PubMed ID: 28137754
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Androgen and inhibin B levels during ovarian stimulation before and after 8 weeks of low-dose hCG priming in women with low ovarian reserve.
    Friis Wang N, Bogstad JW, Petersen MR, Pinborg A, Yding Andersen C, Løssl K.
    Hum Reprod; 2023 Sep 05; 38(9):1807-1815. PubMed ID: 37354554
    [Abstract] [Full Text] [Related]

  • 15. Does dual oocyte retrieval with continuous FSH administration increase the number of mature oocytes in low responders? An open-label randomized controlled trial.
    Boudry L, Mateizel I, Wouters K, Papaleo E, Mackens S, De Vos M, Racca A, Adriaenssens T, Tournaye H, Blockeel C.
    Hum Reprod; 2024 Mar 01; 39(3):538-547. PubMed ID: 38199789
    [Abstract] [Full Text] [Related]

  • 16. Cost-effectiveness of ovarian stimulation agents for IUI in couples with unexplained subfertility.
    van Eekelen R, Wang R, Danhof NA, Mol F, Mochtar M, Mol BW, van Wely M.
    Hum Reprod; 2021 Apr 20; 36(5):1288-1295. PubMed ID: 33615360
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Serum progesterone is lower in ovarian stimulation with highly purified HMG compared to recombinant FSH owing to a different regulation of follicular steroidogenesis: a randomized controlled trial.
    Bosch E, Alamá P, Romero JL, Marí M, Labarta E, Pellicer A.
    Hum Reprod; 2024 Feb 01; 39(2):393-402. PubMed ID: 38037188
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.